结节病患者的长期静脉血栓栓塞风险:一项全国性队列研究
该研究利用丹麦全国登记数据,纳入14,742例新诊断结节病患者并按1:4匹配背景人群,中位随访8.8年。结果显示结节病患者10年VTE绝对风险为2.9% vs 1.6%(P<.0001),诊断后第一年VTE风险比达4.94(95%CI 3.61-6.75),第一年后为1.65(95%CI 1.45-1.87),提示结节病与长期VTE风险升高相关。
要点
- 结节病患者10年VTE绝对风险为2.9%,高于匹配背景人群的1.6%。
- 诊断后第一年VTE风险显著升高(HR 4.94),长期仍持续升高(HR 1.65)。
- 结节病合并VTE患者与无结节病VTE患者的3个月死亡率无显著差异。
核心结论
- 结节病患者与匹配背景人群相比,长期VTE风险显著升高。
研究设计与样本
- 基于丹麦全国登记数据的匹配队列研究,纳入1996-2020年新诊断结节病且无既往VTE的≥18岁患者。
- 结节病患者按年龄、性别和合并症1:4匹配背景人群,共14,742例患者和58,968例对照,中位随访8.8年。
主要发现
- 结节病患者 vs 背景人群的10年绝对风险:VTE为2.9% vs 1.6%(P<.0001),肺栓塞为1.5% vs 0.7%(P<.0001),DVT为1.6% vs 1.0%(P<.0001)。
- 多变量Cox回归显示,诊断后第一年结节病与VTE风险升高相关(HR 4.94;95%CI 3.61-6.75)。
- 诊断第一年后结节病仍与VTE风险升高相关(HR 1.65;95%CI 1.45-1.87)。
- 排除癌症病史患者及随访中删失新发癌症患者后,上述关联持续存在。
- 结节病合并VTE患者与无结节病VTE患者的3个月死亡率无显著差异(校正HR 0.84;95%CI 0.61-1.15)。
临床怎么用
- 对结节病患者应关注VTE的长期风险,尤其在诊断后第一年风险最高。
- 在结节病患者中出现疑似VTE症状时,应提高警惕并及时评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic inflammation is increasingly recognized as a risk factor for VTE, but unlike other inflammatory diseases including systemic lupus erythematosus and rheumatoid arthritis, data on the risk of VTE in patients with sarcoidosis are sparse. RESEARCH QUESTION: Do patients with sarcoidosis have a higher long-term risk of VTE (pulmonary embolism or DVT, and each of these individually) compared with the background population? STUDY DESIGN AND METHODS: Using Danish nationwide registries, patients aged ≥ 18 years with newly diagnosed sarcoidosis (two or more inpatient/outpatient visits, 1996-2020) without prior VTE were matched 1:4 by age, sex, and comorbidities with individuals from the background population. The primary outcome was VTE. RESULTS: We included 14,742 patients with sarcoidosis and 58,968 matched individuals (median age, 44.7 years; 57.2% male). The median follow-up was 8.8 years. Absolute 10-year risks of outcomes for patients with sarcoidosis vs the background population were the following: VTE, 2.9% vs 1.6% (P < .0001), pulmonary embolism, 1.5% vs 0.7% (P < .0001), and DVT, 1.6% vs 1.0% (P < .0001), respectively. In multivariable Cox regression, sarcoidosis was associated with an increased rate of all outcomes in the first year after diagnosis (VTE: hazard ratio [HR], 4.94; 95% CI, 3.61-6.75) and after the first year (VTE: HR, 1.65; 95% CI, 1.45-1.87) compared with the background population. These associations persisted when excluding patients with a history of cancer and censoring patients with incident cancer during follow-up. Three-month mortality was not significantly different between patients with VTE with and without sarcoidosis (adjusted HR, 0.84; 95% CI, 0.61-1.15). INTERPRETATION: In this nationwide cohort study, sarcoidosis was associated with a higher long-term risk of VTE compared with a matched background population.
引用
- Yafasova A, Fosbøl EL, Gustafsson F, et al. Long-Term Risk of VTE in Sarcoidosis: A Nationwide Cohort Study. Chest. 2024. PMID: 38295951. doi:10.1016/j.chest.2024.01.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。